Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.
about
Red cell distribution width and cancerCrosstalk of HNF4α with extracellular and intracellular signaling pathways in the regulation of hepatic metabolism of drugs and lipidsA 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic MyelofibrosisNiche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD-induced myeloproliferation.From leeches to personalized medicine: evolving concepts in the management of polycythemia vera.Immunotherapy based approaches in myelofibrosis.Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients.Intramolecular hydrophobic interactions are critical mediators of STAT5 dimerization.Contemporary insights into the pathogenesis and treatment of chronic myeloproliferative neoplasms.Carotid Artery Stiffness, Digital Endothelial Function, and Coronary Calcium in Patients with Essential Thrombocytosis, Free of Overt Atherosclerotic Disease.The role of the CCN family of proteins in blood cancers.Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer developmentInflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells.Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations.Phosphatidylserine-exposing blood and endothelial cells contribute to the hypercoagulable state in essential thrombocythemia patients.Second malignancies in hydroxyurea and interferon-treated Philadelphia-negative myeloproliferative neoplasms.The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates.The Critical Role of Inflammation in the Pathogenesis and Progression of Myeloid Malignancies.Serum of myeloproliferative neoplasms stimulates hematopoietic stem and progenitor cells.
P2860
Q28066036-CC432433-6FEA-49DC-9B39-90279E7C808CQ28080239-731DC141-5856-4F22-A7F2-E3CB176B34B9Q28553797-57DB8985-EC4F-4E1B-A862-2863BD0E13CCQ33886530-89212993-ED90-461B-9CF2-584F2C74BD9BQ37555790-69BC4D70-44F9-45B9-B7AE-B876EAA1CB7AQ38629189-1C44CAF1-6A40-47C2-BD4E-82FB1F7995E0Q38660742-C82D8F4A-252C-44EA-AAFF-634862AAB2D2Q38810236-EBE3CAE9-8688-4AC6-A472-DFF22DDA79DBQ38848273-3740F6B7-32E1-4B6E-8806-D00E1A77D9DAQ40489397-A6319D0E-7E34-412F-A7DF-2182AC862C60Q41371363-438EE991-7350-46EC-B95B-2D6796B2B095Q41576528-45E443F2-D6F0-4BBF-858F-A35854D20B89Q47116205-7DF67427-D64D-4074-AB07-BD34A1558E49Q47138312-9C38E9DC-318E-4484-8CB2-73B3065EBCC7Q48248231-C0F745F9-22BD-4AA2-98AC-B1E35BC93B22Q51608068-EDE1E7FA-4778-45FE-8D54-C31AE866DCFBQ52584217-85E2E591-7160-48D9-9F2C-250ED9183EF7Q55024258-B811653B-5749-40D4-BFAF-024348ECF5B3Q55334343-59AF193E-9F6C-4CF4-9C60-3507EE309753
P2860
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Myeloproliferative neoplasms a ...... inflammatory process or both.
@en
type
label
Myeloproliferative neoplasms a ...... inflammatory process or both.
@en
prefLabel
Myeloproliferative neoplasms a ...... inflammatory process or both.
@en
P2093
P2860
P50
P356
P1433
P1476
Myeloproliferative neoplasms a ...... inflammatory process or both.
@en
P2093
A Maria Vannucchi
F Cervantes
G Jeryczynski
H Gisslinger
R Hehlmann
R T Silver
P2860
P2888
P304
P356
10.1038/LEU.2016.12
P577
2016-02-08T00:00:00Z
P6179
1036701550